Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acupuncture Therapy | 20 | 2022 | 468 | 6.370 |
Why?
|
Periaqueductal Gray | 11 | 2021 | 120 | 4.620 |
Why?
|
Low Back Pain | 17 | 2022 | 909 | 4.520 |
Why?
|
Pain Perception | 11 | 2021 | 196 | 4.280 |
Why?
|
Placebo Effect | 17 | 2021 | 603 | 3.770 |
Why?
|
Neural Pathways | 29 | 2022 | 3007 | 3.590 |
Why?
|
Brain Mapping | 30 | 2021 | 6548 | 3.060 |
Why?
|
Pain | 27 | 2021 | 4623 | 2.990 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 6 | 2021 | 145 | 2.960 |
Why?
|
Nerve Net | 16 | 2021 | 2147 | 2.920 |
Why?
|
Pain Threshold | 11 | 2020 | 598 | 2.740 |
Why?
|
Vagus Nerve Stimulation | 7 | 2021 | 176 | 2.700 |
Why?
|
Rest | 13 | 2021 | 876 | 2.620 |
Why?
|
Osteoarthritis, Knee | 9 | 2019 | 1184 | 2.570 |
Why?
|
Prefrontal Cortex | 12 | 2021 | 2064 | 2.480 |
Why?
|
Acupuncture Analgesia | 10 | 2019 | 77 | 2.250 |
Why?
|
Pain Measurement | 30 | 2020 | 3518 | 2.160 |
Why?
|
Magnetic Resonance Imaging | 65 | 2022 | 34096 | 2.090 |
Why?
|
Brain | 33 | 2021 | 24936 | 2.080 |
Why?
|
Cerebral Cortex | 18 | 2020 | 5713 | 1.910 |
Why?
|
Fibromyalgia | 4 | 2021 | 361 | 1.870 |
Why?
|
Vagus Nerve | 5 | 2018 | 441 | 1.750 |
Why?
|
Electroacupuncture | 6 | 2015 | 62 | 1.690 |
Why?
|
Analgesia | 5 | 2021 | 467 | 1.510 |
Why?
|
Consciousness | 3 | 2021 | 382 | 1.470 |
Why?
|
Exercise Therapy | 4 | 2021 | 890 | 1.420 |
Why?
|
Parietal Lobe | 5 | 2019 | 820 | 1.390 |
Why?
|
Basal Ganglia | 3 | 2020 | 554 | 1.380 |
Why?
|
Migraine without Aura | 2 | 2020 | 86 | 1.280 |
Why?
|
Hyperalgesia | 5 | 2021 | 499 | 1.260 |
Why?
|
Bell Palsy | 2 | 2017 | 43 | 1.230 |
Why?
|
Gyrus Cinguli | 9 | 2021 | 1084 | 1.220 |
Why?
|
Corpus Striatum | 4 | 2017 | 1255 | 1.190 |
Why?
|
Acupuncture Points | 6 | 2014 | 98 | 1.100 |
Why?
|
Depressive Disorder, Major | 6 | 2018 | 4470 | 1.090 |
Why?
|
Somatosensory Cortex | 5 | 2020 | 535 | 1.040 |
Why?
|
Amygdala | 4 | 2019 | 1280 | 0.930 |
Why?
|
Imagination | 2 | 2020 | 222 | 0.920 |
Why?
|
Anticipation, Psychological | 2 | 2021 | 86 | 0.920 |
Why?
|
Motor Cortex | 2 | 2022 | 955 | 0.900 |
Why?
|
Ventral Tegmental Area | 2 | 2021 | 142 | 0.880 |
Why?
|
Cues | 5 | 2021 | 845 | 0.880 |
Why?
|
Young Adult | 45 | 2021 | 56163 | 0.840 |
Why?
|
Lateral Thalamic Nuclei | 1 | 2020 | 9 | 0.840 |
Why?
|
Adult | 79 | 2021 | 212298 | 0.840 |
Why?
|
Thalamus | 6 | 2022 | 994 | 0.830 |
Why?
|
Catechol O-Methyltransferase | 2 | 2014 | 249 | 0.830 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2020 | 43 | 0.810 |
Why?
|
Limbic System | 2 | 2021 | 441 | 0.760 |
Why?
|
Pulvinar | 1 | 2019 | 23 | 0.760 |
Why?
|
Mind-Body Therapies | 2 | 2021 | 250 | 0.700 |
Why?
|
Male | 90 | 2021 | 351848 | 0.690 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2021 | 260 | 0.680 |
Why?
|
Female | 93 | 2021 | 377269 | 0.670 |
Why?
|
Frontal Lobe | 3 | 2015 | 1424 | 0.660 |
Why?
|
Individuality | 1 | 2019 | 304 | 0.660 |
Why?
|
Reward | 4 | 2016 | 839 | 0.640 |
Why?
|
Visual Cortex | 2 | 2019 | 1140 | 0.620 |
Why?
|
Humans | 122 | 2022 | 709431 | 0.600 |
Why?
|
Ear Auricle | 1 | 2016 | 36 | 0.590 |
Why?
|
Physical Stimulation | 8 | 2019 | 546 | 0.590 |
Why?
|
Arthralgia | 2 | 2018 | 466 | 0.580 |
Why?
|
Tai Ji | 1 | 2019 | 267 | 0.580 |
Why?
|
Hot Temperature | 8 | 2015 | 1321 | 0.580 |
Why?
|
Occipital Lobe | 1 | 2017 | 382 | 0.570 |
Why?
|
Nucleus Accumbens | 1 | 2017 | 357 | 0.560 |
Why?
|
Hypothalamus | 1 | 2021 | 1065 | 0.540 |
Why?
|
Hippocampus | 4 | 2015 | 3653 | 0.520 |
Why?
|
Middle Aged | 52 | 2021 | 215428 | 0.520 |
Why?
|
Placebos | 7 | 2019 | 1773 | 0.520 |
Why?
|
Video Recording | 1 | 2019 | 951 | 0.510 |
Why?
|
Meditation | 2 | 2013 | 233 | 0.510 |
Why?
|
Needles | 4 | 2014 | 443 | 0.500 |
Why?
|
Depressive Disorder | 2 | 2020 | 3886 | 0.490 |
Why?
|
Diffusion Tensor Imaging | 3 | 2022 | 2156 | 0.450 |
Why?
|
Neuronal Plasticity | 2 | 2020 | 1421 | 0.440 |
Why?
|
Qi | 2 | 2008 | 18 | 0.440 |
Why?
|
Conditioning, Classical | 1 | 2014 | 386 | 0.430 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1621 | 0.430 |
Why?
|
Nervous System | 1 | 2015 | 574 | 0.430 |
Why?
|
Cognition | 6 | 2016 | 5948 | 0.420 |
Why?
|
Emotions | 4 | 2016 | 2419 | 0.420 |
Why?
|
Migraine Disorders | 2 | 2021 | 1515 | 0.420 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1290 | 0.410 |
Why?
|
Personality | 1 | 2014 | 527 | 0.400 |
Why?
|
Elder Abuse | 3 | 2016 | 35 | 0.400 |
Why?
|
Visual Perception | 1 | 2019 | 1399 | 0.390 |
Why?
|
Single-Blind Method | 7 | 2021 | 1600 | 0.380 |
Why?
|
Cross-Over Studies | 4 | 2021 | 2013 | 0.380 |
Why?
|
Hyperthermia, Induced | 1 | 2012 | 362 | 0.370 |
Why?
|
Scalp | 2 | 2022 | 375 | 0.360 |
Why?
|
Motivation | 2 | 2018 | 1866 | 0.350 |
Why?
|
Oxygen | 7 | 2018 | 4148 | 0.350 |
Why?
|
Executive Function | 1 | 2016 | 1316 | 0.330 |
Why?
|
Magnetoencephalography | 3 | 2021 | 619 | 0.320 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2017 | 6420 | 0.310 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1858 | 0.310 |
Why?
|
Nursing Homes | 4 | 2016 | 958 | 0.300 |
Why?
|
Learning | 1 | 2015 | 1587 | 0.300 |
Why?
|
Aged | 29 | 2021 | 162592 | 0.300 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2018 | 8971 | 0.290 |
Why?
|
Vision, Ocular | 1 | 2009 | 462 | 0.280 |
Why?
|
Analysis of Variance | 4 | 2021 | 6563 | 0.280 |
Why?
|
Mass Screening | 1 | 2021 | 5186 | 0.270 |
Why?
|
Random Allocation | 3 | 2021 | 2463 | 0.270 |
Why?
|
Peripheral Nerves | 1 | 2007 | 465 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2075 | 0.260 |
Why?
|
Sex Characteristics | 2 | 2011 | 2497 | 0.260 |
Why?
|
Arousal | 1 | 2010 | 1140 | 0.260 |
Why?
|
Bipolar Disorder | 1 | 2021 | 5183 | 0.250 |
Why?
|
Pilot Projects | 7 | 2016 | 8036 | 0.250 |
Why?
|
Forearm | 3 | 2012 | 408 | 0.240 |
Why?
|
Mental Disorders | 2 | 2021 | 6463 | 0.240 |
Why?
|
Treatment Outcome | 15 | 2020 | 61963 | 0.240 |
Why?
|
Diprenorphine | 2 | 2014 | 16 | 0.230 |
Why?
|
Problem Solving | 1 | 2004 | 456 | 0.220 |
Why?
|
Positron-Emission Tomography | 3 | 2014 | 6123 | 0.220 |
Why?
|
Culture | 1 | 2006 | 647 | 0.210 |
Why?
|
Case-Control Studies | 8 | 2020 | 21874 | 0.210 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2723 | 0.210 |
Why?
|
Evoked Potentials | 1 | 2006 | 1033 | 0.210 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3482 | 0.200 |
Why?
|
Catheter Ablation | 2 | 2015 | 2466 | 0.200 |
Why?
|
Liver Neoplasms | 2 | 2015 | 4092 | 0.200 |
Why?
|
Galvanic Skin Response | 2 | 2015 | 354 | 0.200 |
Why?
|
Agnosia | 1 | 2020 | 62 | 0.200 |
Why?
|
Acupuncture | 2 | 2010 | 93 | 0.190 |
Why?
|
Photic Stimulation | 3 | 2015 | 2027 | 0.180 |
Why?
|
Cerebrovascular Circulation | 2 | 2011 | 2749 | 0.180 |
Why?
|
Touch Perception | 1 | 2020 | 118 | 0.180 |
Why?
|
Catastrophization | 2 | 2019 | 316 | 0.180 |
Why?
|
Psychological Tests | 1 | 2021 | 651 | 0.180 |
Why?
|
Echo-Planar Imaging | 2 | 2017 | 660 | 0.180 |
Why?
|
Homeodomain Proteins | 3 | 2018 | 2465 | 0.170 |
Why?
|
Beta Rhythm | 1 | 2018 | 59 | 0.170 |
Why?
|
Longitudinal Studies | 4 | 2020 | 13595 | 0.170 |
Why?
|
Adolescent | 12 | 2021 | 85327 | 0.170 |
Why?
|
Genes, Homeobox | 1 | 2018 | 297 | 0.160 |
Why?
|
Biophysics | 1 | 2017 | 395 | 0.150 |
Why?
|
Facial Muscles | 1 | 2017 | 160 | 0.150 |
Why?
|
Clinical Protocols | 2 | 2012 | 1470 | 0.150 |
Why?
|
Subliminal Stimulation | 1 | 2014 | 10 | 0.140 |
Why?
|
Neuropsychological Tests | 3 | 2016 | 6969 | 0.140 |
Why?
|
Hep G2 Cells | 2 | 2015 | 394 | 0.140 |
Why?
|
Self Administration | 1 | 2016 | 386 | 0.140 |
Why?
|
Back Pain | 1 | 2019 | 541 | 0.130 |
Why?
|
Perceptual Masking | 1 | 2014 | 94 | 0.130 |
Why?
|
Personality Tests | 1 | 2014 | 85 | 0.130 |
Why?
|
Opioid Peptides | 1 | 2014 | 36 | 0.130 |
Why?
|
Regression Analysis | 2 | 2015 | 6515 | 0.130 |
Why?
|
Receptors, Opioid | 1 | 2014 | 153 | 0.130 |
Why?
|
Capsaicin | 1 | 2015 | 237 | 0.130 |
Why?
|
Neck Muscles | 1 | 2014 | 106 | 0.130 |
Why?
|
Brain Waves | 1 | 2018 | 393 | 0.130 |
Why?
|
Homes for the Aged | 1 | 2016 | 261 | 0.130 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 668 | 0.130 |
Why?
|
Apraxias | 1 | 2014 | 60 | 0.130 |
Why?
|
Acupressure | 1 | 2013 | 13 | 0.130 |
Why?
|
Niacinamide | 1 | 2015 | 443 | 0.120 |
Why?
|
Shoulder Pain | 1 | 2014 | 125 | 0.120 |
Why?
|
Music Therapy | 1 | 2014 | 91 | 0.120 |
Why?
|
Neck Pain | 1 | 2014 | 163 | 0.120 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2016 | 518 | 0.120 |
Why?
|
Thinking | 1 | 2016 | 315 | 0.120 |
Why?
|
Gene Duplication | 1 | 2014 | 337 | 0.120 |
Why?
|
Angiotensin I | 1 | 2012 | 59 | 0.120 |
Why?
|
Community-Institutional Relations | 1 | 2014 | 208 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1155 | 0.110 |
Why?
|
Fluoxetine | 1 | 2016 | 772 | 0.110 |
Why?
|
Ear | 1 | 2012 | 177 | 0.110 |
Why?
|
Phenylurea Compounds | 1 | 2015 | 564 | 0.110 |
Why?
|
Research Design | 4 | 2016 | 5860 | 0.110 |
Why?
|
Functional Laterality | 2 | 2009 | 2308 | 0.110 |
Why?
|
Radiography | 4 | 2014 | 6993 | 0.110 |
Why?
|
Lidocaine | 1 | 2015 | 544 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15548 | 0.110 |
Why?
|
Cohort Studies | 4 | 2019 | 39650 | 0.110 |
Why?
|
Nursing Staff | 1 | 2012 | 130 | 0.110 |
Why?
|
Psychomotor Performance | 1 | 2020 | 1952 | 0.110 |
Why?
|
Medically Underserved Area | 1 | 2013 | 238 | 0.110 |
Why?
|
Inservice Training | 1 | 2014 | 401 | 0.100 |
Why?
|
Carotid Artery, Internal | 1 | 2013 | 474 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2019 | 19470 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 554 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 711 | 0.100 |
Why?
|
Aging | 2 | 2021 | 8309 | 0.100 |
Why?
|
Indazoles | 1 | 2012 | 293 | 0.100 |
Why?
|
Awareness | 1 | 2014 | 600 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2014 | 571 | 0.100 |
Why?
|
Adaptation, Psychological | 3 | 2016 | 2583 | 0.100 |
Why?
|
Remission Induction | 1 | 2016 | 2414 | 0.100 |
Why?
|
Hypertension | 3 | 2015 | 8150 | 0.100 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 393 | 0.100 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 553 | 0.090 |
Why?
|
Psychophysics | 2 | 2012 | 307 | 0.090 |
Why?
|
Acetaminophen | 1 | 2013 | 543 | 0.090 |
Why?
|
Reference Values | 2 | 2010 | 5070 | 0.090 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2008 | 27 | 0.090 |
Why?
|
Time Factors | 4 | 2021 | 41295 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2021 | 12008 | 0.090 |
Why?
|
China | 1 | 2015 | 2266 | 0.090 |
Why?
|
Rod Cell Outer Segment | 1 | 2008 | 62 | 0.090 |
Why?
|
Illusions | 1 | 2008 | 56 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2018 | 16161 | 0.090 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2008 | 39 | 0.090 |
Why?
|
New York City | 3 | 2016 | 658 | 0.090 |
Why?
|
Pons | 2 | 2008 | 252 | 0.090 |
Why?
|
Shoulder Joint | 1 | 2014 | 621 | 0.090 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2013 | 553 | 0.090 |
Why?
|
Extremities | 1 | 2014 | 867 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 613 | 0.090 |
Why?
|
Laboratories, Hospital | 1 | 2009 | 199 | 0.090 |
Why?
|
Anesthetics, Local | 1 | 2015 | 988 | 0.080 |
Why?
|
Medicine, Chinese Traditional | 1 | 2008 | 69 | 0.080 |
Why?
|
Counseling | 2 | 2013 | 1500 | 0.080 |
Why?
|
Afferent Pathways | 1 | 2009 | 319 | 0.080 |
Why?
|
Transcription Factors | 3 | 2018 | 11982 | 0.080 |
Why?
|
Psychotherapy | 1 | 2016 | 1552 | 0.080 |
Why?
|
Child | 5 | 2021 | 73998 | 0.080 |
Why?
|
Life Style | 3 | 2015 | 3711 | 0.080 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2008 | 109 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 238 | 0.080 |
Why?
|
New York | 3 | 2016 | 858 | 0.080 |
Why?
|
Brain Stem | 1 | 2012 | 848 | 0.080 |
Why?
|
Neuralgia | 1 | 2012 | 515 | 0.080 |
Why?
|
Evidence-Based Practice | 1 | 2011 | 505 | 0.080 |
Why?
|
Carotid Stenosis | 1 | 2013 | 853 | 0.080 |
Why?
|
Waist Circumference | 1 | 2010 | 906 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 5231 | 0.070 |
Why?
|
Treatment Failure | 1 | 2012 | 2683 | 0.070 |
Why?
|
Minority Groups | 1 | 2013 | 1064 | 0.070 |
Why?
|
Pyrimidinones | 1 | 2008 | 353 | 0.070 |
Why?
|
Parahippocampal Gyrus | 1 | 2006 | 121 | 0.070 |
Why?
|
Neocortex | 1 | 2009 | 389 | 0.070 |
Why?
|
Cell Survival | 2 | 2015 | 6184 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2009 | 3427 | 0.070 |
Why?
|
Sex Factors | 2 | 2010 | 10744 | 0.070 |
Why?
|
Caregivers | 1 | 2016 | 1894 | 0.070 |
Why?
|
Attention | 1 | 2016 | 2442 | 0.070 |
Why?
|
Interpersonal Relations | 1 | 2012 | 1413 | 0.070 |
Why?
|
Telemedicine | 2 | 2013 | 2552 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2656 | 0.070 |
Why?
|
Neural Inhibition | 1 | 2009 | 596 | 0.070 |
Why?
|
Retinal Degeneration | 1 | 2008 | 405 | 0.070 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 447 | 0.070 |
Why?
|
Sensory Thresholds | 2 | 2020 | 404 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 952 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8941 | 0.060 |
Why?
|
Dementia | 1 | 2016 | 2211 | 0.060 |
Why?
|
Social Class | 1 | 2013 | 1980 | 0.060 |
Why?
|
Hemoglobins | 1 | 2009 | 1486 | 0.060 |
Why?
|
Quality of Life | 3 | 2016 | 11553 | 0.060 |
Why?
|
Accidental Falls | 1 | 2011 | 990 | 0.060 |
Why?
|
Home Care Services | 1 | 2009 | 593 | 0.060 |
Why?
|
Electric Stimulation | 1 | 2009 | 1771 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2012 | 2109 | 0.060 |
Why?
|
Exercise | 1 | 2019 | 5269 | 0.060 |
Why?
|
Rhenium | 1 | 2002 | 17 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4385 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2009 | 2422 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3660 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1933 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1117 | 0.050 |
Why?
|
Likelihood Functions | 2 | 2016 | 994 | 0.050 |
Why?
|
Inpatients | 1 | 2012 | 2183 | 0.050 |
Why?
|
Luminescent Proteins | 1 | 2004 | 888 | 0.050 |
Why?
|
Lentivirus | 1 | 2004 | 547 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1104 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2004 | 976 | 0.050 |
Why?
|
Pyrroles | 1 | 2008 | 1206 | 0.050 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2002 | 248 | 0.050 |
Why?
|
Carcinoembryonic Antigen | 1 | 2002 | 358 | 0.050 |
Why?
|
Anemia | 1 | 2009 | 1383 | 0.050 |
Why?
|
Down-Regulation | 1 | 2009 | 3125 | 0.050 |
Why?
|
Radioisotopes | 1 | 2002 | 513 | 0.050 |
Why?
|
Spin Labels | 2 | 2012 | 324 | 0.050 |
Why?
|
Thiadiazoles | 1 | 2000 | 54 | 0.050 |
Why?
|
Muscarinic Agonists | 1 | 2000 | 88 | 0.050 |
Why?
|
Attitude to Health | 1 | 2010 | 2111 | 0.050 |
Why?
|
Perception | 1 | 2007 | 1180 | 0.050 |
Why?
|
Mental Health | 1 | 2013 | 2568 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2016 | 58752 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 22944 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2012 | 5136 | 0.050 |
Why?
|
Mutation | 4 | 2018 | 29242 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2349 | 0.050 |
Why?
|
Apraxia, Ideomotor | 1 | 2018 | 6 | 0.040 |
Why?
|
Cerebellum | 1 | 2006 | 1488 | 0.040 |
Why?
|
Observer Variation | 1 | 2005 | 2696 | 0.040 |
Why?
|
Down Syndrome | 2 | 2016 | 780 | 0.040 |
Why?
|
Reaction Time | 1 | 2004 | 2140 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3712 | 0.040 |
Why?
|
Depression | 1 | 2016 | 7201 | 0.040 |
Why?
|
Neurons | 2 | 2018 | 9397 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2019 | 520 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16295 | 0.040 |
Why?
|
Anisotropy | 1 | 2020 | 1241 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9941 | 0.040 |
Why?
|
Animals | 9 | 2015 | 170647 | 0.040 |
Why?
|
Body Mass Index | 2 | 2013 | 12426 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13763 | 0.040 |
Why?
|
Anxiety | 2 | 2013 | 3880 | 0.040 |
Why?
|
Fragile X Syndrome | 1 | 2016 | 106 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11269 | 0.030 |
Why?
|
Hand Strength | 1 | 2018 | 450 | 0.030 |
Why?
|
Gene Expression | 1 | 2008 | 8069 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 41195 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14895 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9504 | 0.030 |
Why?
|
Cortical Synchronization | 1 | 2014 | 76 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7276 | 0.030 |
Why?
|
Circle of Willis | 1 | 2013 | 72 | 0.030 |
Why?
|
Directive Counseling | 1 | 2015 | 175 | 0.030 |
Why?
|
Signal Transduction | 3 | 2012 | 23985 | 0.030 |
Why?
|
African Americans | 3 | 2015 | 5194 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2013 | 130 | 0.030 |
Why?
|
Retina | 1 | 2004 | 2636 | 0.030 |
Why?
|
Interneurons | 1 | 2018 | 576 | 0.030 |
Why?
|
Dissent and Disputes | 1 | 2014 | 145 | 0.030 |
Why?
|
Taxoids | 1 | 2016 | 659 | 0.030 |
Why?
|
Chronic Disease | 3 | 2014 | 9011 | 0.030 |
Why?
|
Thiourea | 1 | 2012 | 67 | 0.030 |
Why?
|
Sex Offenses | 1 | 2016 | 324 | 0.030 |
Why?
|
Citrulline | 1 | 2012 | 106 | 0.030 |
Why?
|
Mice | 4 | 2015 | 80950 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2012 | 174 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2018 | 1112 | 0.030 |
Why?
|
Group Processes | 1 | 2013 | 232 | 0.030 |
Why?
|
Stroke | 1 | 2013 | 9239 | 0.030 |
Why?
|
Graft Rejection | 1 | 2004 | 4409 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2012 | 561 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2016 | 2195 | 0.020 |
Why?
|
Japan | 1 | 2014 | 1367 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2002 | 2564 | 0.020 |
Why?
|
Molecular Structure | 2 | 2008 | 2020 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2013 | 631 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2012 | 989 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17347 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2238 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2012 | 720 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 19798 | 0.020 |
Why?
|
Aggression | 1 | 2014 | 755 | 0.020 |
Why?
|
Long-Term Care | 1 | 2012 | 598 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2008 | 55 | 0.020 |
Why?
|
Meridians | 1 | 2008 | 6 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 807 | 0.020 |
Why?
|
Buffers | 1 | 2008 | 156 | 0.020 |
Why?
|
Intracellular Fluid | 1 | 2008 | 214 | 0.020 |
Why?
|
Methanol | 1 | 2008 | 87 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2013 | 1043 | 0.020 |
Why?
|
Drug Stability | 1 | 2008 | 309 | 0.020 |
Why?
|
Pyrimidines | 1 | 2000 | 2959 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3412 | 0.020 |
Why?
|
Mood Disorders | 1 | 2014 | 1135 | 0.020 |
Why?
|
Biological Availability | 1 | 2008 | 406 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2008 | 676 | 0.020 |
Why?
|
Blood Glucose | 2 | 2014 | 6262 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3740 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3756 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 1035 | 0.020 |
Why?
|
Acetates | 1 | 2008 | 307 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1833 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 10791 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2008 | 630 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 295 | 0.020 |
Why?
|
Electroretinography | 1 | 2008 | 547 | 0.020 |
Why?
|
Social Support | 1 | 2016 | 2135 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1477 | 0.020 |
Why?
|
Health Education | 1 | 2013 | 1061 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1961 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1482 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2750 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 890 | 0.020 |
Why?
|
Quality Control | 1 | 2008 | 876 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1185 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2008 | 2893 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 2604 | 0.020 |
Why?
|
Pigment Epithelium of Eye | 1 | 2004 | 235 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2008 | 2012 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5233 | 0.020 |
Why?
|
Rats | 2 | 2012 | 25068 | 0.020 |
Why?
|
Homozygote | 1 | 2008 | 1840 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2643 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5525 | 0.010 |
Why?
|
Cell Death | 1 | 2008 | 1740 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2776 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1406 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 2052 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2634 | 0.010 |
Why?
|
Fasting | 1 | 2008 | 1611 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 2002 | 968 | 0.010 |
Why?
|
N-Methylscopolamine | 1 | 2000 | 5 | 0.010 |
Why?
|
Receptor, Muscarinic M1 | 1 | 2000 | 28 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8581 | 0.010 |
Why?
|
Isotope Labeling | 1 | 2002 | 445 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4322 | 0.010 |
Why?
|
Administration, Oral | 1 | 2008 | 3952 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 2000 | 163 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5508 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4696 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8733 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17087 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2000 | 1234 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2200 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13668 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 5242 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 2190 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2443 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15316 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7801 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 26811 | 0.010 |
Why?
|
Alleles | 1 | 2008 | 7123 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2002 | 1353 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10621 | 0.010 |
Why?
|
Calcium | 1 | 2008 | 5808 | 0.010 |
Why?
|
Mice, Nude | 1 | 2002 | 3895 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7505 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 14849 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2004 | 3577 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 2472 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 16795 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8053 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3901 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2002 | 6768 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39394 | 0.010 |
Why?
|
Infant | 1 | 2013 | 34274 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6946 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 23044 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3700 | 0.010 |
Why?
|
Prospective Studies | 1 | 2012 | 50734 | 0.010 |
Why?
|
Protein Binding | 1 | 2000 | 9694 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2000 | 7097 | 0.000 |
Why?
|